Used in the detection and quantification of trophoblast glycoprotein (TPBG), this reference antibody supports research and diagnostic applications in oncology, particularly in studies related to solid tumors such as ovarian, colorectal, and lung cancers. It serves as a critical tool in immunoassays and immunohistochemistry to validate target expression and assess biomarker reliability. Due to its high specificity and consistent performance, it is employed as a benchmark in developing therapeutic antibodies and companion diagnostics. Additionally, it aids in monitoring drug development processes where TPBG is a target, ensuring accuracy and reproducibility across assays.